Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRADA II: Sacubitril/valsartan for Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy
NCT03760588Phase 2Completed
- Sponsor
- Torbjorn Omland
- Start
- Jan 2019
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sacubitril + valsartan in Cardiac dysfunction, sponsored by Torbjorn Omland. Started Jan 2019; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
Cardiac dysfunction
Beyond the preview
Go deeper on NCT03760588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03760588.